معرفی
Richard Malley is a Professor of Pediatrics at Harvard Medical School and a Senior Physician in the Division of Infectious Diseases at Boston Children's Hospital. His research focuses on understanding immune responses to pathogens such as Streptococcus pneumoniae, Staphylococcus aureus, Mycobacterium tuberculosis, and Salmonella, with an emphasis on developing novel vaccines. He leads efforts to create serotype-independent vaccines using whole-cell and MAPS (Multiple Antigen-Presenting System) technologies, which are currently in clinical trials. His work also explores mechanisms of bacterial colonization and pathogenesis, such as the role of the pneumococcal pilus in host interactions.
Education: MD from Tufts University School of Medicine (1990), followed by residency and fellowship training in Pediatrics and Pediatric Infectious Diseases at Boston Children's Hospital (1991–1996).
Research Interests: Vaccine development, innate and adaptive immunity, bacterial pathogenesis, and the interplay between infections and aging. Specific projects include the development of pneumococcal vaccines, studies on IL-17A-mediated immunity, and the use of genomic approaches to identify vaccine targets.
Publications: Over 150 peer-reviewed articles focusing on vaccine efficacy, immune mechanisms in bacterial infections, and translational research in pediatric infectious diseases. Recent work includes clinical trials of novel pneumococcal vaccines and studies on SARS-CoV-2 transmission in children.
Labs/Teams: Leads the Malley Lab at Boston Children's Hospital, collaborating with institutions globally to advance vaccine research. Current projects include MAPS-based vaccines for tuberculosis and Salmonella, and genomic analyses of bacterial virulence factors.
